BibTex format
@article{Mazur-Michałek:2022:10.3390/ijms23105450,
author = {Mazur-Michaek, I and Kowalska, K and Zielonka, D and Leniczak-Staszak, M and Pietras, P and Szaflarski, W and Isalan, M and Mielcarek, M},
doi = {10.3390/ijms23105450},
journal = {International Journal of Molecular Sciences},
title = {Structural abnormalities of the optic nerve and retina in Huntington’s disease pre-clinical and clinical settings},
url = {http://dx.doi.org/10.3390/ijms23105450},
volume = {23},
year = {2022}
}
RIS format (EndNote, RefMan)
TY - JOUR
AB - Huntington’s disease (HD) is a fatal neurodegenerative disorder caused by a polyglutamine expansion in the huntingtin protein. HD-related pathological remodelling has been reported in HD mouse models and HD carriers. In this study, we studied structural abnormalities in the optic nerve by employing Spectral Domain Optical Coherence Tomography (SD-OCT) in pre-symptomatic HD carriers of Caucasian origin. Transmission Electron Microscopy (TEM) was used to investigate ultrastructural changes in the optic nerve of the well-established R6/2 mouse model at the symptomatic stage of the disease. We found that pre-symptomatic HD carriers displayed a significant reduction in the retinal nerve fibre layer (RNFL) thickness, including specific quadrants: superior, inferior and temporal, but not nasal. There were no other significant irregularities in the GCC layer, at the macula level and in the optic disc morphology. The ultrastructural analysis of the optic nerve in R6/2 mice revealed a significant thinning of the myelin sheaths, with a lamellar separation of the myelin, and a presence of myelonoid bodies. We also found a significant reduction in the thickness of myelin sheaths in peripheral nerves within the choroids area. Those ultrastructural abnormalities were also observed in HD photoreceptor cells that contained severely damaged membrane disks, with evident vacuolisation and swelling. Moreover, the outer segment of retinal layers showed a progressive disintegration. Our study explored structural changes of the optic nerve in pre- and clinical settings and opens new avenues for the potential development of biomarkers that would be of great interest in HD gene therapies.
AU - Mazur-Michaek,I
AU - Kowalska,K
AU - Zielonka,D
AU - Leniczak-Staszak,M
AU - Pietras,P
AU - Szaflarski,W
AU - Isalan,M
AU - Mielcarek,M
DO - 10.3390/ijms23105450
PY - 2022///
SN - 1422-0067
TI - Structural abnormalities of the optic nerve and retina in Huntington’s disease pre-clinical and clinical settings
T2 - International Journal of Molecular Sciences
UR - http://dx.doi.org/10.3390/ijms23105450
UR - http://hdl.handle.net/10044/1/97466
VL - 23
ER -